|
|
||||||||
Eur J Cardiothorac Surg 2000;18:136-142
© 2000 Elsevier Science NL
a Department of Thoracic Surgery, Lille University Hospital, Hôpital Calmette, 1 Rue du Professeur J. Leclercq, 59037 Lille Cédex, France
b Department of Pathology, Lille University Hospital, 59037 Lille, France
Received 30 December 1999; received in revised form 30 March 2000; accepted 18 April 2000.
Corresponding author. Tel.: +33-3-2044-4559; fax: +33-3-2044-4890
e-mail: awurtz{at}chru-lille.fr
Objective: To study the results of surgical treatment of primary lung sarcoma. Methods: Between 1982 and 1998, we performed 18 macroscopically complete resections for primary sarcomas of the lung. The records of all patients were reviewed, as were pathological slides. Presence of symptoms, tumour size (more or less than 5 cm), complete resection, TNM stage and histology grade were analyzed for predictors of survival. Results: Patients comprised 11 women and seven men whose age ranged from 19 to 73 years (mean 50 years). Mean tumour diameter was 8.05 cm (range 2.515 cm) There were one grade 1, eight grade 2 and nine grade 3 tumours. Tumours in two patients were unresectable at first presentation, and another was of doubtful resectability according to computed tomography scan. These three patients received pre-operative chemotherapy, with a partial response in the two unresectable patients allowing macroscopically complete resection in both cases. We performed 12 lobectomies (extended to the chest wall in two cases and to the diaphragm in two cases) and six pneumonectomies (extended to the chest wall in one case and the superior vena cava in one case). Operative and 30 days post-operative mortality were nil. Resection margins were invaded in two cases. Six patients received post-operative chemo- or radiotherapy and three others underwent repeat resections for pulmonary sarcoma recurrence. No patients were lost to follow-up. Pulmonary sarcomas recurred in eight patients (44%) leading to death in five cases after a mean period of 17 months. Overall median survival was 48 months, and actuarial 5-year survival 43%. Only TNM stage correlated with significantly increased survival. Conclusion: As complete resection is the best therapeutic option for obtaining an acceptable survival rate in primary pulmonary sarcoma, pre-operative chemotherapy can be a useful adjunct in increasing the resectability of these tumours.
Key Words: Primary sarcoma of the lung Surgery Chemotherapy
This article has been cited by other articles:
![]() |
K. Wiebe, H. Baraki, P. Macchiarini, and A. Haverich Extended pulmonary resections of advanced thoracic malignancies with support of cardiopulmonary bypass Eur. J. Cardiothorac. Surg., April 1, 2006; 29(4): 571 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zonta, F. Lovisetto, P. Morbini, L. Cobianchi, and S. Nazari Thoracic-Abdominal Approach in Primary Pulmonary Synovial Sarcoma Asian Cardiovasc Thorac Ann, March 1, 2005; 13(1): 85 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Park, M. Bacchetta, M. S. Bains, R. J. Downey, R. Flores, V. W. Rusch, and L. N. Girardi Surgical management of thoracic malignancies invading the heart or great vessels Ann. Thorac. Surg., September 1, 2004; 78(3): 1024 - 1030. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.B. Petrov, V.I. Vlassov, G.T. Kalaydjiev, M.A. Plochev, E.D. Obretenov, V.I. Stanoev, and S.E. Danon Primary pulmonary sarcomas and carcinosarcomas - postoperative results and comparative survival analysis Eur. J. Cardiothorac. Surg., April 1, 2003; 23(4): 461 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fischer, M. de Perrot, Y. Sekine, and S. Keshavjee Long-term survival after multiple resections of a fibrosarcoma involving the lung and chest wall Eur. J. Cardiothorac. Surg., August 1, 2001; 20(2): 421 - 423. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |